Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.

Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378 · see citing works

Untitled work

(1976) · Medical Entomology and Zoology · Cited by 8,899 · see citing works

Clinical Global Impression

Guy, W. L. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-65186-5_300379 · Cited by 1,441 · see citing works

Transport of brain-derived neurotrophic factor across the blood–brain barrier

Pan, W., Banks, W. A., Fasold, M. B., Bluth, J., & Kastin, A. J. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00141-5 · Cited by 1,354 · see citing works

What does the PANSS mean?

Leucht, S., Kane, J., Kissling, W., Hamann, J., Etschel, E., & Engel, R. R. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.008 · Cited by 1,230 · see citing works

Infusion of Brain-Derived Neurotrophic Factor into the Lateral Ventricle of the Adult Rat Leads to New Neurons in the Parenchyma of the Striatum, Septum, Thalamus, and Hypothalamus

Pencea, V., Bingaman, K. D., Wiegand, S. J., & Luskin, M. B. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06706.2001 · Cited by 928 · see citing works

Evidence for a release of brain-derived neurotrophic factor from the brain during exercise

Rasmussen, P., Brassard, P., Adser, H., Pedersen, M. V., Leick, L., Hart, E., Secher, N. H., Pedersen, B. K., & Pilegaard, H. (2009) · Experimental Physiology · doi:10.1113/expphysiol.2009.048512 · Cited by 914 · see citing works

The impact of age, weight and gender on BDNF levels in human platelets and plasma

Lommatzsch, M., Zingler, D., Schuhbaeck, K., Schloetcke, K., Zingler, C., Schuff‐Werner, P., & Virchow, J. C., Jr. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.002 · Cited by 849 · see citing works

Blood BDNF Concentrations Reflect Brain-Tissue BDNF Levels across Species

Klein, A. B., Williamson, R., Santini, M. A., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G. M., & Aznar, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000738 · Cited by 726 · see citing works

Brain-Derived Neurotrophic Factor/TrkB Signaling in Memory Processes

Yamada, K., & Nabeshima, T. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.91.267 · Cited by 585 · see citing works

BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis

Polyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., & Schroeter, M. L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.044 · Cited by 488 · see citing works

Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., & Carr, V. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.88 · Cited by 453 · see citing works

Determinants of serum brain-derived neurotrophic factor.

Bus, B. A. A., Molendijk, M. L., Penninx, B. J. W. H., Buitelaar, J. K., Kenis, G., Prickaerts, J., Elzinga, B. M., & Voshaar, R. C. O. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.013 · Cited by 279 · see citing works

Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology

Pillai, A., Kale, A. A., Joshi, S., Naphade, N. M., Raju, M. S. V. K., Nasrallah, H. A., & Mahadik, S. P. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991015 · Cited by 273 · see citing works

A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays

Polacchini, A., Metelli, G., Francavilla, R., Baj, G., Florean, M., Mascaretti, L. G., & Tongiorgi, E. (2015) · Scientific Reports · doi:10.1038/srep17989 · Cited by 263 · see citing works

Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications

Fernandes, B. S., Steiner, J. H., Berk, M., Molendijk, M. L., González-Pinto, A. M., Turck, C. W., Nardin, P., & Ca, G. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.117 · Cited by 250 · see citing works

Long-Term Outcome of Patients with Schizophrenia: A Review

Jobe, T. H., & Harrow, M. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505001403 · Cited by 239 · see citing works

The neurobiology and treatment of first-episode schizophrenia

Kahn, R. S., & Sommer, I. E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.66 · Cited by 219 · see citing works

Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments

Piccinni, A., Marazziti, D., Catena, M., Domenici, L., Debbio, A. D., Bianchi, C., Mannari, C., Martini, C., Pozzo, E. D., Schiavi, E., et al. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.05.005 · Cited by 206 · see citing works

The role of BDNF in the pathophysiology and treatment of schizophrenia

Favalli, G. P. D. S., Li, J., Belmonte-de-Abreu, P. S., Wong, A. H. C., & Daskalakis, Z. J. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.022 · Cited by 197 · see citing works

Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm

Begliuomini, S., Lenzi, E., Ninni, F., Casarosa, E., Merlini, S., Pluchino, N., Valentino, V., Luisi, S. V., Luisi, M., & Genazzani, A. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-07-0376 · Cited by 176 · see citing works

Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics

Xiu, M. H., Hui, L., Dang, Y. F., Hou, T. D., Zhang, C. X., Zheng, Y. L., Chen, D. C., Kosten, T. R., & Zhang, X. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.011 · Cited by 172 · see citing works

Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics

GRILLO, R., Ottoni, G. L., Leke, R., Souza, D. O., Portela, L. V., & Lara, D. R. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.005 · Cited by 159 · see citing works

Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics

Tan, Y. L., Zhou, D. F., Cao, L. Y., Zou, Y. Z., & Zhang, X. Y. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.02.054 · Cited by 146 · see citing works

Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes

Chen, D. C., Wang, J., Wang, B., Yang, S. C., Zhang, C. X., Zheng, Y. L., Li, Y. L., Wang, N., Yang, K. B., Xiu, M. H., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1665-6 · Cited by 136 · see citing works

Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients

HUANG, T., & Lee, C. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.11.004 · Cited by 127 · see citing works

Investigation of serum BDNF levels in drug-naive patients with schizophrenia.

Rizos, E., Rontos, I., Laskos, E., Arsenis, G., Michalopoulou, P., Vasilopoulos, D., Gournellis, R., & Lykouras, L. (2008) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.04.007 · Cited by 127 · see citing works

Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia

Jindal, R. D., Pillai, A. K., Mahadik, S. P., Eklund, K., Montrose, D. M., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.035 · Cited by 122 · see citing works

Neurotrophic factors and the pathophysiology of schizophrenic psychoses

Durany, N., & Thome, J. (2004) · European Psychiatry · doi:10.1016/j.eurpsy.2004.06.020 · Cited by 111 · see citing works

Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia

Reis, H. J., Nicolato, R., Barbosa, I. G., do Prado, P. H. T., Romano‐Silva, M. A., & Teixeira, A. L. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.022 · Cited by 100 · see citing works

Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia

Asevedo, E. D. M., Gadelha, A., Noto, C. D. S., Mansur, R. B., Zugman, A., Belangero, S. I., Berberian, A. D. A., Scarpato, B. S., Leclerc, E., Teixeira, A. L., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.032 · Cited by 99 · see citing works

Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients.

Hori, H., Yoshimura, R., Yamada, Y., Ikenouchi, A., Mitoma, M., Ida, Y., & Nakamura, J. (2007) · PubMed · doi:10.1097/yic.0b013e3280103593 · Cited by 83 · see citing works

BDNF and NGF Signalling in Early Phases of Psychosis: Relationship With Inflammation and Response to Antipsychotics After 1 Year

Martínez‐Cengotitabengoa, M., MacDowell, K. S., Alberich, S., Diaz, F., García‐Bueno, B., Rodríguez–Jiménez, R., Bioque, M., Berrocoso, E., Parellada, M., Lobo, A., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv078 · Cited by 76 · see citing works

Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation

Pedrini, M., Chendo, I., Grande, I., Lobato, M. I. R., Belmonte-de-Abreu, P. S., Lersch, C., Walz, J. C., Kauer‐Sant’Anna, M., Kapczinski, F. P., & Gama, C. S. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.039 · Cited by 70 · see citing works

Increased Plasma Brain-Derived Neurotropic Factor, Not Nerve Growth Factor-Beta, in Schizophrenia Patients with Better Response to Risperidone Treatment

Lee, B.-H., & Kim, Y. (2009) · Neuropsychobiology · doi:10.1159/000205518 · Cited by 69 · see citing works

Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics

González-Pinto, A. M., Mosquera, F., Palomino, A., Alberich, S., Gutiérrez, A., Haidar, K., Vega, P., Barbeito, S., Jauregi, A. O., & Matute, C. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328338bc5a · Cited by 63 · see citing works

Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia

Wysokiński, A. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1087592 · Cited by 60 · see citing works

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients

Yoshimura, R., Hori, H., Sugita, A., Ueda, N., Kakihara, S., Umene, W., Nakano, Y., Shinkai, K., Mitoma, M., Ohta, M., et al. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.010 · Cited by 58 · see citing works

Gender difference in association of cognition with BDNF in chronic schizophrenia

Zhang, X. Y., Chen, D., Tan, Y., Tan, S., Wang, Z., Yang, F., Xiu, M., Hui, L., Lv, M., Zunta‐Soares, G. B., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.004 · Cited by 56 · see citing works

Association of Serum Brain-Derived Neurotrophic Factor and Duration of Untreated Psychosis in First-Episode Patients with Schizophrenia

Rizos, E., Michalopoulou, P., Siafakas, N., Stefanis, N., Douzenis, A., Rontos, I., Laskos, E., Kastania, A., Zoumpourlis, V. C., & Lykouras, L. (2010) · Neuropsychobiology · doi:10.1159/000315438 · Cited by 54 · see citing works

Nicotine dependence and serum BDNF levels in male patients with schizophrenia

Zhang, X. Y., Xiu, M. H., Chen, D. C., Yang, F. D., Wu, G. Y., Lü, L., Kosten, T. A., & Kosten, T. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1956-y · Cited by 53 · see citing works

Effects of antipsychotic drugs on the expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal cultures

Park, S. W., Lee, C. H., Cho, H. Y., Seo, M. K., Lee, J. G., Lee, B. J., Seol, W., Kee, B. S., & Kim, Y. H. (2013) · Synapse · doi:10.1002/syn.21634 · Cited by 47 · see citing works

Effects of antipsychotics on the serum BDNF levels in schizophrenia

Chen, C.-C., & Huang, T. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.01.011 · Cited by 47 · see citing works

Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment

Lee, A. H., Lange, C., Ricken, R., Hellweg, R., & Lang, U. E. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31821895c1 · Cited by 47 · see citing works

Changes in Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor‐Beta in Schizophrenic Patients Before and After Treatment

Ajami, A., Hosseini, S. H., Taghipour, M., & Khalilian, A. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12158 · Cited by 43 · see citing works

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients

Yoshimura, R., Ueda, N., Hori, H., Ikenouchi, A., Umene‐Nakano, W., & Nakamura, J. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802309617 · Cited by 43 · see citing works

Association of biomarkers and depressive symptoms in schizophrenia

Noto, C. D. S., Gadelha, A., Belangero, S. I., Smith, M. D. A. C., de Aguiar, B. W., Panizzutti, B., Mari, J. D. J., Gama, C. S., Bressan, R. A., & Brietzke, E. M. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.10.042 · Cited by 42 · see citing works

Peptide Immunoreactivity in Aged Rat Cortex and Hippocampus as a Function of Memory and BDNF Infusion

Croll, S. D., Chesnutt, C. R., Greene, N. A., Lindsay, R. M., & Wiegand, S. J. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00122-7 · Cited by 37 · see citing works

A Longitudinal Study of Alterations of Hippocampal Volumes and Serum BDNF Levels in Association to Atypical Antipsychotics in a Sample of First-Episode Patients with Schizophrenia

Rizos, E. N., Papathanasiou, M. A., Michalopoulou, P. G., Laskos, E., Mazioti, A., Kastania, A., Vasilopoulou, K., Nikolaidou, P., Margaritis, D., Papageorgiou, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087997 · Cited by 36 · see citing works

Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients

Nikolac Perkovic, M., Nedic Erjavec, G., Zivkovic, M., Sagud, M., Uzun, S., Mihaljevic-Peles, A., Kozumplik, O., Muck-Seler, D., & Pivac, N. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3515-4 · Cited by 35 · see citing works

The influence of aripiprazole, olanzapine and enriched environment on depressant-like behavior, spatial memory dysfunction and hippocampal level of BDNF in prenatally stressed rats

Nowakowska, E., Kus, K., Ratajczak, P., Cichocki, M., & Woźniak, A. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.12.008 · Cited by 33 · see citing works

Increase in Serum Brain-Derived Neurotrophic Factor in Met Allele Carriers of the BDNF Val66Met Polymorphism Is Specific to Males

Bus, B. A. A., Vásquez, A. A., Franke, B., Prickaerts, J., Graaf, J. D., & Voshaar, R. C. O. (2012) · Neuropsychobiology · doi:10.1159/000336997 · Cited by 31 · see citing works

A close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers

Yoshimura, R., Ikenouchi, A., Hori, H., Umene‐Nakano, W., Hayashi, K., Katsuki, A., Ueda, N., & Nakamura, J. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501003748560 · Cited by 31 · see citing works

Effects of antipsychotic drugs on the expression of synapse-associated proteins in the frontal cortex of rats subjected to immobilization stress

Seo, M. K., Lee, C. H., Cho, H. Y., You, Y. S., Lee, B. J., Lee, J. G., Park, S. W., & Kim, Y. H. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.098 · Cited by 30 · see citing works

High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder

Lam, R. W. M. (2007) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000277959.60604.d1 · Cited by 30 · see citing works

Vascular Endothelial Growth Factor and Brain-Derived Neurotrophic Factor in Quetiapine Treated First-Episode Psychosis

Murphy, B., Pang, T. Y., Hannan, A. J., Proffitt, T., McConchie, M., Kerr, M., Markulev, C., O’Donnell, C. P., McGorry, P. D., & Berger, G. E. (2014) · Schizophrenia Research and Treatment · doi:10.1155/2014/719395 · Cited by 30 · see citing works

Smoking and BDNF Val66Met polymorphism in male schizophrenia: A case-control study

Zhang, X. Y., Chen, D., Tan, Y., Luο, X., Zuo, L., Lv, M., Shah, N. N., Zunta‐Soares, G. B., & Soares, J. C. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.09.023 · Cited by 23 · see citing works

Lower Brain-Derived Neurotropic Factor Levels in Untreated Adolescents With First-Episode Psychosis

Şimşek, Ş., Gençoğlan, S., Yüksel, T., Kaplan, İ., & Aktaş, H. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000378 · Cited by 19 · see citing works

Levels of Serum Brain-Derived Neurotrophic Factor in Schizophrenia

Lee, J., Nurjono, M., & Lee, T.-S. W. (2016) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000463 · Cited by 11 · see citing works

BDNF and S100B in psychotic disorders: evidence for an association with treatment responsiveness

van de Kerkhof, N. W. A., Fekkes, D., der Heijden, F. M. M. A. V., & Verhoeven, W. M. A. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2013.59 · Cited by 8 · see citing works

Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation

Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750 · see citing works

Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

Robertson, O. D., Coronado, N. G., Sethi, R., Berk, M., & Dodd, S. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12775 · Cited by 52 · see citing works

Drug Targets in Neurotrophin Signaling in the Central and Peripheral Nervous System

Kashyap, M. P., Roberts, C. M., Waseem, M., & Tyagi, P. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0885-3 · Cited by 50 · see citing works

Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics

Álvarez-Herrera, S., Escamilla-Orozco, R. I., Contreras, O. M., Saracco, R., Flores-Medina, Y., Hurtado‐Alvarado, G., Maldonado-García, J. L., Becerril‐Villanueva, E., Pérez‐Sánchez, G., & Pavón, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00195 · Cited by 47 · see citing works

Peripheral BDNF Response to Physical and Cognitive Exercise and Its Association With Cardiorespiratory Fitness in Healthy Older Adults

Tarassova, O., Ekblom, M., Moberg, M., Lövdén, M., & Nilsson, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01080 · Cited by 40 · see citing works

An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial

Pawełczyk, T., Grancow-Grabka, M., Trafalska, E., Szemraj, J., Żurner, N., & Pawełczyk, A. M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05258-4 · Cited by 38 · see citing works

Impact of neuroinflammation on brain glutamate and dopamine signalling in schizophrenia: an update

Nayak, U., Manikkath, J., Arora, D., & Mudgal, J. (2025) · Metabolic brain disease · doi:10.1007/s11011-025-01548-3 · Cited by 22 · see citing works

Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram

Šagud, M., Perković, M. N., Dvojkovic, A., Jakšić, N., Vuksan‐Ćusa, B., Živković, M., Kušević, Z., Mihaljević-Peleš, A., & Pivac, N. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05790-2 · Cited by 23 · see citing works

BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study

Wu, Z. W., Shi, H., Chen, D. C., Chen, S., Xiu, M. H., & Zhang, X. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104879 · Cited by 22 · see citing works

The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

Martínez-Pinteño, A., Mezquida, G., Bioque, M., López-Ilundain, J. M., Andreu-Bernabeu, Á., Zorrilla, E. P., Mané, A., Rodríguez–Jiménez, R., Corripio, I., Sarró, S., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.02.003 · Cited by 17 · see citing works

1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia

Białoń, M., Chocyk, A., Majcher‐Maślanka, I., Żarnowska, M., Michalski, K., Antkiewicz‐Michaluk, L., & Wąsik, A. (2021) · Pharmacological Reports · doi:10.1007/s43440-020-00209-9 · Cited by 14 · see citing works

Elevated brain-derived neurotrophic factor (BDNF) serum levels in an acute episode of schizophrenia in polish women: Correlation with clinical and metabolic parameters.

Skibińska, M., Kapelski, P., Rajewska‐Rager, A., Szczepankiewicz, A., Narożna, B., Duda, J., Budziński, B., Hauser, J., Dmitrzak‐Węglarz, M., & Pawlak, J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.11.041 · Cited by 11 · see citing works

Effects of antidepressant and antipsychotic medication on peripheral brain-derived neurotrophic factor concentration: Systematic review and meta-analysis

Merabtine, T., Tarhini, Z., Preux, P., Christou, N., & Jost, J. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115946 · Cited by 10 · see citing works

The mediating effect of brain-derived neurotrophic factor levels on childhood trauma and psychiatric symptoms in patients with first-episode schizophrenia

Wang, L., Yin, Y., Zhou, Y., Huang, J., Zhang, P., Chen, S., Fan, H., Cui, Y., Luο, X., Tan, S., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674211031478 · Cited by 9 · see citing works

Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression

Rajačić, B. K., Šagud, M., Begić, D., Perković, M. N., Dvojkovic, A., Ganoci, L., & Pivac, N. (2023) · Biomolecules · doi:10.3390/biom13091425 · Cited by 9 · see citing works

Association between reduced plasma BDNF concentration and MMSE scores in both chronic schizophrenia and mild cognitive impairment

Gredičak, M., Perković, M. N., Erjavec, G. N., Uzun, S., Kozumplik, O., Štrac, D. Š., & Pivac, N. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111086 · Cited by 8 · see citing works

Changes in serum levels of brain-derived neurotrophic factor with electroconvulsive therapy and pharmacotherapy and its clinical correlates in male schizophrenia patients

Akbas, I., & Balaban, Ö. D. (2021) · Acta Neuropsychiatrica · doi:10.1017/neu.2021.40 · Cited by 8 · see citing works

Rs7219 Regulates the Expression of GRB2 by Affecting miR-1288-Mediated Inhibition and Contributes to the Risk of Schizophrenia in the Chinese Han Population

Yang, J., Guo, X., Zhu, L., Huang, J., Long, J., Chen, Q., Pan, R., Chen, Z., Wu, X., & Su, L. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0639-9 · Cited by 7 · see citing works

Effects of tamoxifen alone and in combination with risperidone on hyperlocomotion, hippocampal structure and bone in ketamine-induced model of psychosis in rats

Sedky, A. A., Raafat, M. H., Hamam, G. G., Sedky, K. A., & Magdy, Y. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00470-0 · Cited by 5 · see citing works

Long-term effects of antipsychotics on serum BDNF levels in patients with schizophrenia

Mikulić, F. L., Šagud, M., Perković, M. N., Mikulić, S. K., Ganoci, L., Janović, M. B., Janović, Š., Simunovic, I. F., Peleš, A. M., Bozicevic, M., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111240 · Cited by 4 · see citing works

Zavod za kliničku psihijatriju: jučer, danas i sutra

Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Šagud, M., Medicinski fakultet Sveučilišta u Zagrebu, Z., Mihaljević-Peleš, A., Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Medicinski fakultet Sveučilišta u Zagrebu, Z., Ćusa, B. V., Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Medicinski fakultet Sveučilišta u Zagrebu, Z., Kuzman, M. R., et al. (2022) · Socijalna psihijatrija · doi:10.24869/spsih.2022.110

Zavod za kliničku psihijatriju: jučer, danas i sutra

Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Šagud, M., Medicinski fakultet Sveučilišta u Zagrebu, Z., Mihaljević-Peleš, A., Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Medicinski fakultet Sveučilišta u Zagrebu, Z., Ćusa, B. V., Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Medicinski fakultet Sveučilišta u Zagrebu, Z., Kuzman, M. R., et al. (2022) · Socijalna psihijatrija · doi:10.24869/psihei.2022.110

Razvoj sestrinstva na Klinici za psihijatriju i psihološku medicinu Kliničkog bolničkog centra Zagreb

Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Božičević, M., Medicinski fakultet Sveučilišta u Zagrebu, Z., Bradaš, Z., Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Medicinski fakultet Sveučilišta u Zagrebu, Z., Dragija, L., Klinika za psihijatriju i psihološku medicinu, K. B. C. Z., Medicinski fakultet Sveučilišta u Zagrebu, Z., Aurer, Z., et al. (2022) · Socijalna psihijatrija · doi:10.24869/spsih.2022.187

BDNF as a potential predictor of cardiac and depressive outcomes in patients 6- months after PCI with stent placement

Medved, S., Mihaljević-Peleš, A., Bulum, J., Sović, S., Ganoci, L., Božina, N., Janović, M. B., Šagud, M., & Jurak, I. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111442

Additional file 1 of Effects of tamoxifen alone and in combination with risperidone on hyperlocomotion, hippocampal structure and bone in ketamine-induced model of psychosis in rats

Sedky, A. A., Raafat, M. H., Hamam, G. G., Sedky, K. A., & Magdy, Y. (2022) · Figshare · doi:10.6084/m9.figshare.19731788

Increase in Brain-derived Neurotrophic Factor in Patients with Schizophrenia Treated with Olanzapine: A Systemic Review and Meta-analysis

Lin, P. (2012) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2012.02.002 · Cited by 4 · see citing works

Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics

Rizos, E. N., Παπαδοπούλου, Α., Laskos, E., Michalopoulou, P. G., Kastania, A., Vasilopoulos, D., Katsafouros, K., & Lykouras, L. P. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970802182733 · Cited by 113 · see citing works

Reduced Brain-Derived Neurotrophic Factor Serum Concentrations in Acute Schizophrenic Patients Increase During Antipsychotic Treatment

Lee, A. H., Lange, C., Ricken, R., Hellweg, R., & Lang, U. E. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31821895c1 · Cited by 47 · see citing works

Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment

Pırıldar, Ş., Gönül, A. S., Taneli, F., & Akdeniz, F. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.008 · Cited by 142 · see citing works

Long-term effects of antipsychotics on serum BDNF levels in patients with schizophrenia

Mikulić, F. L., Šagud, M., Perković, M. N., Mikulić, S. K., Ganoci, L., Janović, M. B., Janović, Š., Simunovic, I. F., Peleš, A. M., Bozicevic, M., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111240 · Cited by 4 · see citing works